Bruker Corp. (BRKR)
61.56
+1.23
(+2.04%)
USD |
NASDAQ |
Nov 13, 16:00
61.56
0.00 (0.00%)
After-Hours: 17:09
Bruker Enterprise Value : 10.82B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 10.82B |
| November 11, 2026 | 11.14B |
| November 10, 2026 | 11.11B |
| November 09, 2026 | 11.77B |
| November 06, 2026 | 10.97B |
| November 05, 2026 | 10.47B |
| November 04, 2026 | 11.35B |
| November 03, 2026 | 10.23B |
| November 02, 2026 | 10.11B |
| October 30, 2026 | 10.32B |
| October 29, 2026 | 11.07B |
| October 28, 2026 | 11.07B |
| October 27, 2026 | 10.88B |
| October 26, 2026 | 10.50B |
| October 23, 2026 | 10.40B |
| October 22, 2026 | 10.36B |
| October 21, 2026 | 10.63B |
| October 20, 2026 | 10.15B |
| October 19, 2026 | 10.06B |
| October 16, 2026 | 9.973B |
| October 15, 2026 | 10.24B |
| October 14, 2026 | 10.10B |
| October 13, 2026 | 10.19B |
| October 12, 2026 | 10.19B |
| October 09, 2026 | 10.59B |
| Date | Value |
|---|---|
| October 08, 2026 | 10.45B |
| October 07, 2026 | 10.72B |
| October 06, 2026 | 10.84B |
| October 05, 2026 | 11.36B |
| October 02, 2026 | 11.26B |
| October 01, 2026 | 11.06B |
| September 30, 2026 | 11.49B |
| September 29, 2026 | 11.48B |
| September 28, 2026 | 11.30B |
| September 25, 2026 | 11.43B |
| September 24, 2026 | 11.41B |
| September 23, 2026 | 10.75B |
| September 22, 2026 | 10.98B |
| September 21, 2026 | 11.04B |
| September 18, 2026 | 11.01B |
| September 17, 2026 | 11.26B |
| September 16, 2026 | 10.90B |
| September 15, 2026 | 10.15B |
| September 14, 2026 | 9.680B |
| September 11, 2026 | 9.797B |
| September 10, 2026 | 9.817B |
| September 09, 2026 | 9.949B |
| September 08, 2026 | 10.55B |
| September 04, 2026 | 10.57B |
| September 03, 2026 | 10.71B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.97B |
| Danaher Corp. | 185.41B |
| Thermo Fisher Scientific, Inc. | 294.59B |
| Bio-Rad Laboratories, Inc. | 9.660B |
| Harvard Bioscience, Inc. | 81.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -109.70M |
| Revenue (Quarterly) | 874.00M |
| Total Expenses (Quarterly) | 985.80M |
| EPS Diluted (Quarterly) | -0.8052 |
| Gross Profit Margin (Quarterly) | 49.19% |
| Profit Margin (Quarterly) | -12.55% |
| Earnings Yield | -1.78% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 1.158 |